Conditions: Primary CNS Lymphoma; Refractory Primary CNS Lymphoma; Relapsed Primary CNS Lymphoma
Interventions: Biological: Tisagenlecleucel
Sponsors: Matthew J. Frigault, M.D.; Novartis
Active, not recruiting
16726 items (16726 unread) in 74 feeds